Thesis_Alexander Posted - 8 hours ago

$BMY The following excerpt is from the BofA conference, conducted on May 15, 2024, and might be helpful in attempting to forecast Q2 2024 revenues from the growth portfolio. "So as we're looking at that business, we're looking at a double-digit, about 10% growth, Q1 to Q2 sequentially for Sotyktu and Zeposia, and Orencia is probably going to be a single digit sequential growth for Q2." Sotyktu (Deucravacitinib) - Q1 (24) revenues $44,000,000 ~ Q2 (24) revenues $48,400,000 Zeposia (Azanimod) - Q1 (24) revenues $110,000,000 ~ Q2 (24) revenues $121,400,000 Orencia (Abatacept) - Q1 (24) revenues $798,000,000 ~ Q2 (24) revenues $830,000,000

trigger_finger Posted - 1 day ago

$BMY I need a new shovel for my Ira account. It broke loading shares at this level.

Thesis_Alexander Posted - 1 day ago

$BMY "Cantor expects that Bristol-Myers Squibb Co (NYSE:BMY), which acquired Karuna Therapeutics’ KarXT, will likely come to market before AbbVie’s antipsychotic emraclidine and become the leading drug." https://markets.businessinsider.com/news/stocks/abbvie-is-successfully-positioned-to-absorb-humira-biosimilar-erosion-analyst-1033400477

Thesis_Alexander Posted - 1 day ago

$BMY Jenny Talkington discusses the basis of the decision to acquire shares of Bristol Myers Squibb on CNBC's Halftime Report. https://www.msn.com/en-us/money/news/trade-tracker-goldman-sachs-bristol-myers-and-tjx/vi-BB1mA3xw?ocid=socialshare

Marco_Polo Posted - 1 day ago

$CBRL I believe the dividend cut was excessive. This tactical error brings into question Opportunity Cost. Am I paid properly to wait while they get their situation together? I took my profits over to $BMY for a beat down powerhouse with a 5% yield. Always remember to keep position size manageable. Blow ups happen so we always mitigate risk.

Long__Strong Posted - 1 day ago

$LLY $BMY $PFE Take a look at $RMSL FDA clearance expected before end of June. The device has already been heavily examined by the Fed & they only came back with minor questions. This device is superior to anything currently available globally. Do some DD to confirm my statements here & buy a few hundred thousand shares at minimum. A 10x to 15x return incoming shortly. GLTA

Thesis_Alexander Posted - 1 day ago

$BMY

Trending__Now Posted - 1 day ago

$BMY I have my alert set up for when the share price drops below, 43.77. That's when we picked up another 20 Calls. Someone is selling, and someone is buying. It's been bouncing off that certain area. Check your charts. Still believe we are headed over $45 next week. Have a great weekend.

BobBijawk Posted - 1 day ago

$CKPT $pfe $lly $bmy $gsk Checkpoint 34 millin shares on market. Phase three trial that outperformed keytruda and regenrons libatayo. once approved teh revenue potential for this one idication is aproximately 350 million . Do the math . Libtayo has stacked up multiple approvals and have around 800 millino in sales annually today. use that figure 800 million times it by 2 . 2.4 billion dollars is stealing Ckpt . Discount your calculations for a few share offerings and come up with a price target. LOL I am buying this gem . they will surely get apporval in NSCLC and unseat Keytruda and Libtayo at the top dog in that indication. they ahd a crl for 3rd party manu . same thing as IBRX and IBRX was approved after satisfying same thing goes for cosibelimab.

frankwhite718 Posted - 1 day ago

$BMY damn ya sucked me back in!

CDMO Posted - 1 day ago

$BMY bought more of this trash. Karuna pdufa will push this higher soon

Fingerlickengood Posted - 2 days ago

$IOVA $PFE $JNJ $BMY

GuyBurgessQ Posted - 2 days ago

$BMY 🤡🔫. Sell some drugs dammit.

Thesis_Alexander Posted - 2 days ago

$BMY I suspect that the price may trade sideways and further decline in the next two months in the event of failure to recover today's depreciated value tomorrow or Monday and evidence of a positive change in direction of advancement.

Fingerlickengood Posted - 2 days ago

$IOVA $PFE $JNJ $BMY

Fingerlickengood Posted - 2 days ago

$IOVA $PFE $JNJ $BMY

Thesis_Alexander Posted - 2 days ago

$BMY The transcript from yesterday's BofA Global Healthcare Conference contains some valuable insight on the company's scope and the market's concern with Camzyos' potential competitor. https://www.bms.com/assets/bms/us/en-us/pdf/investor-info/boa-global-healthcare-conference-20224-transcript.pdf

TalkMarkets Posted - 2 days ago

#Walmart #Earnings And The State Of The Consumer $BMY $WMT $SPY https://talkmarkets.com/content/stocks--equities/walmart-earnings-and-the-state-of-the-consumer?post=446011

Thesis_Alexander Posted - 2 days ago

$BMY "TD Cowen maintains $67 target on Bristol-Myers Squibb https://www.investing.com/news/company-news/td-cowen-maintains-67-target-on-bristolmyers-squibb-93CH-3444796

Trending__Now Posted - 2 days ago

$BMY Today was LEAPS. Jan 16/26 Calls. Spread them out across the $45 to $55. Breakeven from $50.85 to $57.50. Of course, in the next 610 days I'd be nice for the share price to hit $75 again and in one year time that might be closer than we think now. If you're interested in doing the same, don't tie up large amounts of capital. It's one of those "what the heck" scenario's where LEAPS appear to be under priced. I'm actually hoping for a $65 during this time and after recovering my initial investment making 14 per contract to a low of $7 per contract. However, loss of working capital is probably the worst and I'll get my money back. Good luck.

RedBear Posted - 2 days ago

$BMY can I get this at $40. What do you think?

Do_The_Opposite Posted - 2 days ago

$AUPH What if we hear breaking news at 5pm like the old days today $BMY buying Aurinia all cash deal 15 bucks

STOCKPICKERTRADER Posted - 2 days ago

$BMY nothing to see here but another product approval and revenue stream coming online! FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously Treated Follicular Lymphoma BENZINGA 11:56 AM ET 05/16/2024 Wednesday, the FDA granted accelerated approval to Bristol Myers Squibb (BMY) Co’s Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for relapsed or refractory follicular lymphoma. This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s). In April, following an investigation announced in November last year, the FDA said it would now require boxed warnings—the highest safety-related caution for medications—for all chimeric antigen receptor (CAR) T-cell therapies.

GuyBurgessQ Posted - 2 days ago

$BMY Sucking again. Typical. Isn't there a drug 2cure this ailing pile of garbage?

Fixaleg Posted - 2 days ago

@dloeb @STOCKPICKERTRADER like that group as well and picked up more shares today as well! $BMY $CSCO $BABA $PFE

dloeb Posted - 2 days ago

@STOCKPICKERTRADER both are way undervalued with nice dividend and low valuations. Bought both of these too! $PFE $BMY $CSCO $BABA Also had added to some other positions this morning

STOCKPICKERTRADER Posted - 2 days ago

$BMY FDA Approves Expanded Use Of Bristol Myers Squibb's Breyanzi Cancer Cell Therapy For Previously Treated Follicular Lymphoma BENZINGA 11:56 AM ET 05/16/2024 Wednesday, the FDA granted accelerated approval to Bristol Myers Squibb (BMY) Co’s Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed chimeric antigen receptor (CAR) T cell therapy, for relapsed or refractory follicular lymphoma. This indication is approved under accelerated approval based on response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trial(s). In April, following an investigation announced in November last year, the FDA said it would now require boxed warnings—the highest safety-related caution for medications—for all chimeric antigen receptor (CAR) T-cell therapies.

STOCKPICKERTRADER Posted - 2 days ago

$BMY picked up some shares here and $CSCO to build out some positions and bottom fish

BuyingDipsSellingRips Posted - 2 days ago

$BMY $PFE cus it’s election year?

Eurofighter Posted - 2 days ago

$BMY 40 i think could be the bottom...